grant
Retinoblastoma Phase II Expanded Access Clinical Trial
Organization TARGETED THERAPY TECHNOLOGIES, LLCLocation SOMERSET, UNITED STATESPosted 15 Sept 2024Deadline 30 Jun 2029
FDANIHUS FederalResearch GrantFY2024
Description preview
Abstract
Retinoblastoma (RB) is a micro-orphan disease intraocular cancer in infants and children (typically diagnosed
between birth and 5 years of age). Approximately 250 new cases are diagnosed annually in the United States.
Standard of care for retinoblastoma includes removing the affected eye (safest) or attempted salvage of the eye
starting…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click